Tego Science Inc banner
T

Tego Science Inc
KOSDAQ:191420

Watchlist Manager
Tego Science Inc
KOSDAQ:191420
Watchlist
Price: 13 490 KRW
Market Cap: ₩109.4B

Tego Science Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Tego Science Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
T
Tego Science Inc
KOSDAQ:191420
EPS (Diluted)
-₩405
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
EPS (Diluted)
₩4.7k
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
17%
SK Bioscience Co Ltd
KRX:302440
EPS (Diluted)
-₩732
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Voronoi Inc
KOSDAQ:310210
EPS (Diluted)
-₩1.9k
CAGR 3-Years
-14%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
EPS (Diluted)
₩2.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
55%
A
ABL Bio Inc
KOSDAQ:298380
EPS (Diluted)
-₩734
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
No Stocks Found

Tego Science Inc
Glance View

Market Cap
109.4B KRW
Industry
Biotechnology

Tego Science, Inc. engages in the manufacture and sale of cell therapy products. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-11-06. is a Korea-based company mainly engaged in the research and development, manufacture and distribution of wound-healing skin cell therapy products. The Company’s products mainly consist of cell therapy products, and laboratory cultured skin models.

Intrinsic Value
14 750.45 KRW
Undervaluation 9%
Intrinsic Value
Price ₩13 490
T

See Also

What is Tego Science Inc's EPS (Diluted)?
EPS (Diluted)
-405.7 KRW

Based on the financial report for Sep 30, 2025, Tego Science Inc's EPS (Diluted) amounts to -405.7 KRW.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett